Parkinsons Disease Conferences | Europe | Asia | Middle East | Canada | Japan | Australia | USA

Parkinsons Disease

Parkinson's disease, a movement disorder, is a progressive neurological disorder, the condition progresses over time. In Parkinson's disease, the cells which are responsible to secrete dopamine begin to die. Dopamine is responsible for the smooth functioning of the muscle of the body. Dopamine is secreted by the cells of the substantia nigra, a part of the brain.

Parkinson's disease symptoms including the change in voice, slurry voice, tremor, slow movements, anosmia, balancing problem, stiffness of arms, legs and trunks, facial expression start to change, and loss of sense of smell. These symptoms are due to a decrease in levels of dopamine leading to abnormal brain activity.

The cause which leads to low levels of dopamine is not yet clear. But there are many factors which lead to Parkinson's disease, maybe genetic factors and environmental causes. As there is no specific test to diagnose Parkinson's disease, a dopamine transporter test scan can be used.

Sub-tracks:

Signs and symptoms of Parkinson's disease
Secondary Parkinsonism
Parkinsonian gait
Brain cell death
Parkinsonism
Bradykinesia
Parkinson’s care, rehabilitation, and treatments

Market Analysis: The Parkinson's Disease market is projected to experience a Compound Annual Growth Rate (CAGR) of approximately 6.66% between 2025 and 2030, though forecasts vary among research reports. This variance stems from differing market scopes, with some analyses focusing solely on drug markets (e.g., Mordor Intelligence at 3.58%) while others include broader diagnosis and treatment (e.g., TowardsHealthcare.com at 8.9%). Other projections for the market range from 5.04% (Grand View Research) to over 8% (Fortune Business Insights, Global Market Insights Inc.). These figures are forecasts, and their accuracy can be influenced by methodology, included market segments, and evolving market dynamics.

Tracks